IN2013MU02526A - - Google Patents

Info

Publication number
IN2013MU02526A
IN2013MU02526A IN2526MU2013A IN2013MU02526A IN 2013MU02526 A IN2013MU02526 A IN 2013MU02526A IN 2526MU2013 A IN2526MU2013 A IN 2526MU2013A IN 2013MU02526 A IN2013MU02526 A IN 2013MU02526A
Authority
IN
India
Prior art keywords
sequence
expression vector
encoding
production
host cell
Prior art date
Application number
Other languages
English (en)
Inventor
Sanjay Sonar
Archana Krishnan
Damodar Thappa
Original Assignee
Biogenomics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogenomics Ltd filed Critical Biogenomics Ltd
Priority to SG11201600682PA priority Critical patent/SG11201600682PA/en
Priority to IN2526MU2013 priority patent/IN2013MU02526A/en
Priority to PCT/IN2014/000504 priority patent/WO2015015516A2/en
Priority to US14/908,791 priority patent/US9803207B2/en
Priority to EP14789419.0A priority patent/EP3027643A2/en
Publication of IN2013MU02526A publication Critical patent/IN2013MU02526A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN2526MU2013 2013-07-31 2014-07-31 IN2013MU02526A (hr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SG11201600682PA SG11201600682PA (en) 2013-07-31 2014-07-31 Expression vector for production of recombinant proteins in prokaryotic host cells
IN2526MU2013 IN2013MU02526A (hr) 2013-07-31 2014-07-31
PCT/IN2014/000504 WO2015015516A2 (en) 2013-07-31 2014-07-31 Expression vector for production of recombinant proteins in prokaryotic host cells
US14/908,791 US9803207B2 (en) 2013-07-31 2014-07-31 Expression vector for production of recombinant proteins in prokaryotic host cells
EP14789419.0A EP3027643A2 (en) 2013-07-31 2014-07-31 Expression vector for production of recombinant proteins in prokaryotic host cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2526MU2013 IN2013MU02526A (hr) 2013-07-31 2014-07-31

Publications (1)

Publication Number Publication Date
IN2013MU02526A true IN2013MU02526A (hr) 2015-06-26

Family

ID=51794934

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2526MU2013 IN2013MU02526A (hr) 2013-07-31 2014-07-31

Country Status (5)

Country Link
US (1) US9803207B2 (hr)
EP (1) EP3027643A2 (hr)
IN (1) IN2013MU02526A (hr)
SG (1) SG11201600682PA (hr)
WO (1) WO2015015516A2 (hr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3307766A4 (en) 2015-06-11 2019-06-12 Genexine, Inc. MODIFIED INTERLEUKIN-7 PROTEIN AND USES THEREOF
KR102386735B1 (ko) * 2015-11-06 2022-04-14 주식회사 제넥신 변형된 인터루킨-7 융합 단백질의 제형
US11357827B2 (en) 2015-12-04 2022-06-14 Genexine, Inc. Method for preventing or treating influenza virus infection using pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion protein
WO2017095191A1 (ko) * 2015-12-04 2017-06-08 주식회사 제넥신 면역글로불린 fc가 융합된 인터루킨-7 융합 단백질을 포함하는 사람 파필로마바이러스 유래 질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100358948B1 (ko) 2000-03-31 2002-10-31 한국과학기술원 인체 과립성 백혈구의 콜로니 자극인자를 분비하는 대장균
CN1164755C (zh) 2001-09-05 2004-09-01 南京大学 一种改善外源基因在大肠杆菌中可溶性表达的方法
EP2787083B1 (en) 2009-11-09 2017-06-14 The Regents of the University of Colorado, a body corporate Efficient production of peptides
IN2013MU02527A (hr) 2013-07-31 2015-06-26 Biogenomics Ltd

Also Published As

Publication number Publication date
WO2015015516A3 (en) 2015-04-02
EP3027643A2 (en) 2016-06-08
US9803207B2 (en) 2017-10-31
US20160186190A1 (en) 2016-06-30
WO2015015516A2 (en) 2015-02-05
SG11201600682PA (en) 2016-02-26

Similar Documents

Publication Publication Date Title
MX2023001834A (es) Anticuerpos antimiostatina, polipeptidos que contienen regiones fc variantes, y metodos de uso.
PH12018501280A1 (en) Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use
PH12018502645A1 (en) Optimized mini-dystrophin genes and expression cassettes and their use
MX2023007211A (es) Anticuerpos antimiostatina y metodos de uso.
IL261979A (en) A mammalian cell line for protein production and a breeding library
MX2023011785A (es) Metodos y composiciones para produccion de proteina de clara de huevo.
IN2015DN02771A (hr)
MX2017006866A (es) Pares de unión para producción de péptidos.
MX2017007127A (es) Composiciones que comprenden polipeptidos que tienen actividad xilanasa y polipeptidos que tienen actividad arabinofuranosidasa.
UY34254A (es) Proteínas y péptidos modificados.
TR201909037T4 (tr) Yeni protein deamidaz.
MX2015013447A (es) Polipeptidos que tienen actividad de la fosfolipasa a y polinucleotidos que los codifican.
MX2020003508A (es) Un factor de secrecion de proteinas con alta eficacia secretora y un vector de expresion que lo comprende.
MX2020012356A (es) Sobreexpresion de reguladores de la ruta de n-glicosilacion para modular la glicosilacion de proteinas recombinantes.
MX2015010078A (es) Uso de polipeptidos con actividad proteasa en alimentos para animales.
PH12016501689B1 (en) Tatk-cdkl5 fusion proteins, compositions, formulations, and use thereof
IN2013MU02526A (hr)
HK1207879A1 (en) An optimized gene sequence encoding for the l1 protein of human papillomavirus type 31 31 l1
IN2013MU02527A (hr)
MX2015012281A (es) Proteinas de union a tnf mejoradas.
MX2017005295A (es) Marcador de seleccion novedoso para transfeccion celular y produccion de proteinas.
MX2016005572A (es) Uso de monensina para regular la glicosilacion de proteinas recombinantes.
EP3000890A4 (en) Alphaviral vectors and cell lines for producing recombinant proteins
EP2970916A4 (en) LEPIDOPTER INSECT CELLS SUITABLE FOR THE PRODUCTION OF RECOMBINANT PROTEINS
RU2012133162A (ru) Способ получения рекомбинантных белков в бесклеточных системах синтеза